Research advances in abnormal lipid metabolism of lung cancer

doi:10.19401/j.cnki.1007-3639.2021.01.010

China Oncology ›› 2021, Vol. 31 ›› Issue (1): 76-80.doi: 10.19401/j.cnki.1007-3639.2021.01.010

• Review • Previous Articles Next Articles

Research advances in abnormal lipid metabolism of lung cancer

ZHANG Cuicui, QIN Tingting, MENG Zhaoting, LI Kai#br#

Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Lung Cancer Center, Tianjin 300060, China

Online:2021-01-30 Published:2021-02-23
Contact: LI Kai E-mail: likai_fnk@163.com

Abstract

Abstract: Recent study has found that lipid metabolism has close relation to the occurrence, development and therapy of lung cancer and gradually becomes a hot topic in cancer cell metabolism. Analyzing the relationship between lipid metabolism and lung cancer may be helpful for accurate diagnosis, prediction of therapeutic efficacy and estimation of prognosis. Additionally, it is possible to develop drugs for tumor lipid metabolism. Therefore, this paper reviewed the characteristics of blood lipid in patients with lung cancer, their relationship to therapeutic efficacy and the medicines for lipid metabolism. This can provide reference for treatment targeting lipid metabolism in lung cancer.

Key words: Lung cancer, Lipid metabolism, Correlation

ZHANG Cuicui, QIN Tingting, MENG Zhaoting, LI Kai. Research advances in abnormal lipid metabolism of lung cancer[J]. China Oncology, 2021, 31(1): 76-80.

[1]	WANG Zezhou , ZHANG Yang , MO Miao , YUAN Jing , ZHOU Changming , SHEN Jie , FENG Xiaoshuang , WU Haoxuan , LI Hang , YE Ting , HU Hong , CHEN Haiquan , ZHENG Ying . Distribution of metastatic sites and survival analysis of patients with non-metastatic lung cancer at initial diagnosis based on hospital registration [J]. China Oncology, 2021, 31(9): 775-782.
[2]	LU Li, LU Renquan, SUN Jiajun, LU Ning, GUO Lin. The application of serum N-MID in auxiliary diagnosis and therapeutic effect monitoring of bone metastasis in patients with primary lung cancer [J]. China Oncology, 2021, 31(9): 838-844.
[3]	ZHU Yihui, LI Ting, HU Xichun. Clinical research progress and prospect of trastuzumab deruxtecan [J]. China Oncology, 2021, 31(8): 754-761.
[4]	LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun . miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene [J]. China Oncology, 2021, 31(7): 581-588.
[5]	YANG Jia , LIU Shuyuan , WANG Yingying , LI Yingfu , MA Qianli , LI Yu , WANG Yongrong , LI Chuanyin , TAN Fang . The association of polymorphisms in TNF-α gene with non-small cell lung cancer in Han population of Yunnan Province [J]. China Oncology, 2021, 31(7): 616-628.
[6]	JIANG Chaoyang , WANG Juan , ZHANG Ling , GAO Hui , ZHANG Tao , LI Zhihui . Correlation analysis of neck node levels in 709 cases of nasopharyngeal carcinoma [J]. China Oncology, 2021, 31(7): 629-634.
[7]	XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia. The advances in immunotherapy biomarkers of small cell lung cancer [J]. China Oncology, 2021, 31(7): 635-639.
[8]	QIAO Tingting , GE Shujing , LUO Yuan , LU Chengrong , DUAN Lianning . Mechanism of inhibition of epithelial-to-mesenchymal transition by phosphorylated H2AX in lung cancer cells [J]. China Oncology, 2021, 31(4): 277-284.
[9]	MU Lina , SU Jia , YU Shunzhang , NIU Rungui , HAN Xiaoyou , LIU Li , SHI Jianping , ZHANG Zuofeng . The control of lung cancer relating to quitting active smoking and secondary smoking: a case-control study of lung cancer in Taiyuan [J]. China Oncology, 2021, 31(4): 335-343.
[10]	YI Weili , ZHAO Wencheng , HUANG Dongning , QIN Li , WU Xintian , ZHOU Fei , WU Fengying . Analysis of immune-related adverse events and its correlation with efficacy of anti-PD-1 monotherapy in advanced non-small cell lung cancer [J]. China Oncology, 2021, 31(3): 203-211.
[11]	ZHAO Yuanyuan , ZHOU Jianying , FAN Yun , WANG Jialei , HUANG Dingzhi , LI Junling , SHI Meiqi , LIU Jiwei , YAO Yu , WU Lin , YAO Wenxiu , ZHANG Li . Advances in the treatment of BRAF V600-mutant non-small cell lung cancer [J]. China Oncology, 2021, 31(12): 1145-1152.
[12]	WU Ran , WANG Guizhen , CHENG Xin , ZHOU Guangbiao . The effects of copper ion on cell proliferation and the clinical significance of copper ion in lung cancer [J]. China Oncology, 2021, 31(11): 1072-1080.
[13]	SHEN Yujia , FU Xiaolong . Research progress of immune contexture in tumorigenesis, progression and prognostic relevance of non-small cell lung cancer [J]. China Oncology, 2021, 31(11): 1115-1125.
[14]	LIU Qian , QIAO Meng , MAO Shiqi , YANG Shuo , LIU Yiwei , ZHAO Chao , LI Xuefei , REN Shengxiang , ZHOU Caicun . Impact of metastatic organ on prognosis in extensive-stage small cell lung cancer [J]. China Oncology, 2021, 31(1): 45-51.
[15]	HE Xi, JIAO Xiaodong, ZANG Yuansheng. Clinical research progress of tumor mutational burden in EGFR-mutant advanced non-small cell lung cancer [J]. China Oncology, 2021, 31(1): 69-75.

Research advances in abnormal lipid metabolism of lung cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments